阳性活检核心率对中等风险前列腺癌中低剂量率支臂治疗结果的影响

Yoshito Kusuhara1, Tomoya Fukawa2, Tomoharu Fukumori3

  • 1Department of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.

Anticancer research
|September 29, 2023
PubMed
概括

活检阳性核心比率预测中等风险前列腺癌 (PCa) 治疗低剂量率支臂治疗 (LDR-BT) 的复发. 格里森等级组3 (GG3) PCa的患者尤其如此,这表明它对预测结果的重要性.